How gallstones form
Approximately 80% of gallstones are cholesterol stones — formed when bile becomes supersaturated with cholesterol relative to bile salts and phospholipids. The cholesterol lithogenicity index (CLI) measures this ratio: a CLI above 1.0 means bile is supersaturated and stone formation is likely over time.
Risk factors for gallstone formation:
- Female sex (oestrogen increases biliary cholesterol secretion — the “4 F’s”: Female, Fat, Forty, Fertile)
- Obesity and metabolic syndrome — elevated hepatic cholesterol synthesis and secretion into bile
- Rapid weight loss — gallbladder empties poorly during caloric restriction, allowing stasis and crystallisation
- High triglycerides and dyslipidaemia — shared metabolic pathways with biliary cholesterol excess
Spirulina’s relevant mechanisms
GLA and hepatic cholesterol secretion
Spirulina’s GLA reduces hepatic VLDL synthesis — the same mechanism responsible for its triglyceride- lowering effect. Reduced hepatic cholesterol synthesis means less cholesterol secreted into bile, directly reducing biliary cholesterol saturation.
The clinical observation: spirulina reduces serum LDL by approximately 10 mg/dL across multiple RCTs. Bile cholesterol tracks serum cholesterol — lower serum LDL correlates with lower biliary cholesterol secretion.
Animal model: gallstone prevention
In a hamster model of high-cholesterol diet-induced gallstones, spirulina supplementation significantly reduced gallstone incidence compared to untreated controls. The mechanism attributed was reduced hepatic cholesterol synthesis and improved bile salt composition.
No human trial has specifically tested spirulina for gallstone prevention or management.
Phycocyanin and biliary inflammation
Biliary inflammation (cholecystitis) is a consequence of both calculous disease (stone-induced) and acalculous disease (infection or ischaemia). Phycocyanin’s NF-κB inhibition is anti-inflammatory in biliary epithelial cells — potentially relevant to reducing the inflammatory component of cholecystitis.
Triglyceride reduction and VLDL
Elevated triglycerides increase biliary sludge and gallstone risk through a separate mechanism from cholesterol — VLDL particles are preferentially secreted into bile and contribute to biliary sludge formation. Spirulina’s consistent triglyceride reduction (−44 mg/dL mean across RCTs) is directly relevant to this mechanism.
Active gallstone disease: important considerations
For people with existing gallstones or gallbladder disease, several considerations apply:
GLA and bile stimulation
GLA (as all dietary fats) stimulates cholecystokinin release, which causes gallbladder contraction. For people with asymptomatic gallstones, this is generally harmless and may actually reduce stone stasis (regular gallbladder emptying is protective against stone accumulation).
For people with known large gallstones and symptomatic disease, any dietary fat can trigger biliary colic by causing the stone to move. Spirulina’s fat content (3–5% of dry weight, mostly GLA and PUFA) is modest — 0.15–0.25 g fat per 5 g — unlikely to trigger biliary colic on its own.
Post-cholecystectomy (after gallbladder removal)
After gallbladder removal, bile flows continuously into the duodenum rather than being concentrated and released in response to meals. Some people experience post-cholecystectomy diarrhoea from continuous bile acid exposure to the colon.
Spirulina use post-cholecystectomy is safe and potentially beneficial — the cholesterol-lowering effects remain relevant for cardiovascular risk management (gallstone disease and cardiovascular disease share the same metabolic risk factors).
Who benefits most from spirulina’s gallbladder-relevant effects
- People with metabolic syndrome and dyslipidaemia:The same patients who benefit from spirulina’s cardiovascular effects have elevated gallstone risk. Managing lipids reduces both risks simultaneously.
- People undergoing intentional weight loss:Rapid weight loss is a major gallstone trigger. Maintaining adequate dietary fat (including GLA from spirulina) and bile stimulation during weight loss reduces gallstone risk during the weight reduction process.
- Post-menopausal women:Oestrogen replacement therapy increases gallstone risk; post-menopausal women are already at elevated risk. Spirulina’s lipid effects are specifically relevant.
Practical guidance
- For gallstone prevention (no current disease):5 g/day spirulina as part of a low-cholesterol, anti-inflammatory diet. The cholesterol and triglyceride reduction mechanisms are the primary benefit.
- For people with asymptomatic gallstones:Spirulina is likely safe and potentially beneficial for cholesterol management. Discuss with gastroenterologist.
- For people with symptomatic gallstone disease awaiting surgery:Keep fat intake including spirulina modest to minimise biliary colic risk. Spirulina’s fat content alone is insufficient to trigger attacks, but caution is reasonable.
- After cholecystectomy: Normal spirulina use is appropriate; no special precautions needed.